TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer says he doesn't think the Monsanto (MON) and Bayer (BAYN) merger will be approved by regulators. 'The idea that these two companies can get together is fanciful,' Cramer said, drawing similarities to the proposed merger of Dow Chemical (DOW) and DuPont (DD) , which is facing regulatory scrutiny.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.